Recall All Batches of pharmaceutical products manufactured by Les Laboratoires Medis
2024-01-03Product Description :
الاسم التجاري |
الاسم العلمي |
رقم التسجيل |
رقم التشغيلة المتأثرة |
الشركة الصانعة |
Trade Name |
Scientific Name |
Register Number |
Affected batch number |
Manufacturer |
MEDICAINE 2% CARTRIDGE |
MEPIVACAINE HYDROCHLORIDE,ADRENALINE |
2-560-12 |
جميع التشغيلات حتى تاريخه |
LES LABORATOIRES MEDIS |
MEDICAINE 3% CARTRIDGE |
MEPIVACAINE HYDROCHLORIDE |
3-560-12 |
||
OMECURE 40 MG POWDER FOR I.V. INJECTION |
OMEPRAZOLE |
3008222563 |
||
FLUKAS 200 VIAL |
FLUCONAZOLE |
5-560-12 |
||
FLUKAS 100 VIAL |
FLUCONAZOLE |
4-560-12 |
||
ZOTIMOS 4MG VIAL |
ZOLEDRONIC ACID |
12-560-19 |
||
TOSTAF 500 mg Vial |
VANCOMYCIN |
1709234220 |
||
TEICO 200 mg Vial |
TEICOPLANIN |
1411234468 |
||
TEICO 400 mg Vial |
TEICOPLANIN |
1411234470 |
||
MEPROSON 40MG POWDER FOR INJECTION |
METHYLPREDNISOLONE |
10-560-19 |
||
MEPROSON 500 MG POWDER FOR INJECTION |
METHYLPREDNISOLONE SODIUM SUCCINATE |
11-560-19 |
||
LEVODIS 5 mg/ml Solution For Injection |
LEVOFLOXACIN |
2803233438 |
||
REMIFENTANIL MEDIS 1 MG VIAL |
REMIFENTANIL HYDROCHLORIDE |
13-560-19 |
||
REMIFENTANIL MEDIS 5 MG VIAL |
REMIFENTANIL HYDROCHLORIDE |
14-560-19 |
||
ONDANSETRON MEDIS 8MG F.C.TABLET |
ONDANSETRON |
15-560-19 |
||
FENTANYL MEDIS 10 ml Ampoule |
FENTANYL |
1512211479 |
||
FENTANYL MEDIS 2 ml Ampoule |
FENTANYL |
1512211480 |
||
ENOXA |
ENOXAPARIN SODIUM |
2906222278 |
||
ENOXA |
ENOXAPARIN SODIUM |
2906222279 |
||
ENOXA |
ENOXAPARIN SODIUM |
2906222280 |
||
ENOXA |
ENOXAPARIN SODIUM |
2906222281 |
||
Paracetamol Medis |
PARACETAMOL |
1206233787 |
Issue :
SFDA has issued a recall of all products above due to GMP non-compliance based on inspection observations during the visit that carried out at Les laboratoires medis which may affect the quality and safety of finished pharmaceutical product.
Recommendations :
For healthcare professionals,Stop dispensing the above products immediately. Embargo/Quarantine all remaining stock. Affected batch should be returned to the supplier.
for patients
- Consult your healthcare provider prior to discontinuing use of the affected products, or for any health concerns.
- Contact the recalling firm or SFDA if you have any questions about the recall.
- Adverse reactions or quality problems experienced with the use of this product may be reported to Saudi Vigilance either online or call center (Call 19999).